Analyze interleukin-1β, interleukin-6, and tumor necrosis factor-α levels in dry eye and the therapeutic effect of cyclosporine A

Table 5 NEI-VFQ-25 score detection

Group	n	Time	Mobility barriers	Visual impairment	Health conditions
Control group	62	Before treatment	80.34 ± 3.12	85.12 ± 4.35	55.23 ± 3.54
		After treatment	92.12 ± 3.52a	90.23 ± 5.12a	61.23 ± 4.12a
Study group	62	Before treatment	80.34 ± 4.11	85.45 ± 3.25	56.23 ± 4.12
		After treatment	99.67 ± 3.64a,c	99.34 ± 3.25a,c	68.84 ± 3.81a,c

Data are mean ± standard deviation.

^aP < 0.05 for comparison of before and after treatment in the same group.

^cP < 0.05 for comparison to the control group and study group at the same time.